MAPT and Alzheimer disease: In the brains of AD patients, UCH-L1 is co-localized with the hyperphosphorylated and abnormal ubiquitinated tau proteins, and the level of soluble UCH-L1 protein is inversely proportional to the number of NFTs [105].